RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG

Elena Milanesi; Irena Voinsky; Adva Hadar; Carlo Maj; John R. Kelsoe; Tatyana Shekhtman; Peter Zandi; Fernando Goes; James B. Potash; Michael Greshovits; Shlomit Gilad; Massimo Gennarelli; Thomas G. Schulze; David Gurwitz

doi:10.1016/j.euroneuro.2016.09.428

RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG

Elena Milanesi, Irena Voinsky, Adva Hadar, Carlo Maj, John R. Kelsoe, Tatyana Shekhtman, Peter Zandi, Fernando Goes, James B. Potash, Michael Greshovits, Shlomit Gilad, Massimo Gennarelli, Thomas G. Schulze, David Gurwitz

Human Molecular Genetics Biochemistry

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S391-S392
Journal	European Neuropsychopharmacology
Volume	27
DOIs	https://doi.org/10.1016/j.euroneuro.2016.09.428
State	Published - Oct 2017

Access to Document

10.1016/j.euroneuro.2016.09.428

Cite this

Milanesi, E., Voinsky, I., Hadar, A., Maj, C., Kelsoe, J. R., Shekhtman, T., Zandi, P., Goes, F., Potash, J. B., Greshovits, M., Gilad, S., Gennarelli, M., Schulze, T. G., & Gurwitz, D. (2017). RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG. European Neuropsychopharmacology, 27, S391-S392. https://doi.org/10.1016/j.euroneuro.2016.09.428

@article{097b1e98f66a4cd9b209a25623144f52,

title = "RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG",

author = "Elena Milanesi and Irena Voinsky and Adva Hadar and Carlo Maj and Kelsoe, \{John R.\} and Tatyana Shekhtman and Peter Zandi and Fernando Goes and Potash, \{James B.\} and Michael Greshovits and Shlomit Gilad and Massimo Gennarelli and Schulze, \{Thomas G.\} and David Gurwitz",

year = "2017",

month = oct,

doi = "10.1016/j.euroneuro.2016.09.428",

language = "אנגלית",

volume = "27",

pages = "S391--S392",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier B.V.",

}

Milanesi, E, Voinsky, I, Hadar, A, Maj, C, Kelsoe, JR, Shekhtman, T, Zandi, P, Goes, F, Potash, JB, Greshovits, M, Gilad, S, Gennarelli, M, Schulze, TG & Gurwitz, D 2017, 'RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG', European Neuropsychopharmacology, vol. 27, pp. S391-S392. https://doi.org/10.1016/j.euroneuro.2016.09.428

TY - JOUR

T1 - RNA-SEQUENCING OF BIPOLAR DISORDER PATIENTS LYMPHOBLASTOID CELL LINES IMPLICATES A NOVEL NEUROTROPHIC FACTOR IN THE EFFICACY OF LITHIUM AS MOOD STABILIZING DRUG

AU - Milanesi, Elena

AU - Voinsky, Irena

AU - Hadar, Adva

AU - Maj, Carlo

AU - Kelsoe, John R.

AU - Shekhtman, Tatyana

AU - Zandi, Peter

AU - Goes, Fernando

AU - Potash, James B.

AU - Greshovits, Michael

AU - Gilad, Shlomit

AU - Gennarelli, Massimo

AU - Schulze, Thomas G.

AU - Gurwitz, David

PY - 2017/10

Y1 - 2017/10

U2 - 10.1016/j.euroneuro.2016.09.428

DO - 10.1016/j.euroneuro.2016.09.428

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.abstract???

SN - 0924-977X

VL - 27

SP - S391-S392

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -